MOSAIC MITRAL BIOPROSTHETIC VALVE
Report
- Report Number
- 2025587-2022-00977
- Event Type
- Injury
- Date Received
- April 13, 2022
- Date of Event
- September 15, 2021
- Report Date
- April 13, 2022
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- LWR
- PMA / PMN Number
- P990064
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
CITATION: YOSHIKAWA ET AL. LONG-TERM OUTCOMES OF THE MOSAIC MITRAL PORCINE BIOPROSTHESIS IN JAPAN: RESULTS FROM THE JAPAN MOSAIC VALVE LONG-TERM MULTICENTER STUDY. CIRC J. 2022 FEB 25;86(3):449-457. DOI: 10.1253/CIRCJ.CJ-21-0528. EPUB 2021 SEP 15. EARLIEST DATE OF PUBLISH USED FOR DATE OF EVENT. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. WITHOUT RETURN OF THE PRODUCT NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATIONS. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING LONG-TERM OUTCOMES OF THE MOSAIC MITRAL PORCINE BIOPROSTHESIS IN JAPAN. ALL DATA WERE COLLECTED FROM MULTIPLE JAPANESE CENTERS BETWEEN 1999 AND 2014. THE STUDY POPULATION INCLUDED 390 PATIENTS (PREDOMINANTLY FEMALE, MEDIAN AGE 73 YEARS). ALL PATIENTS WERE IMPLANTED WITH A MEDTRONIC MOSAIC BIOPROSTHETIC VALVE (UNIQUE DEVICE IDENTIFIER NUMBERS NOT PROVIDED). AMONG ALL PATIENTS, THERE WERE 105 DEATHS DURING THE STUDY PERIOD. THE EARLY MORTALITY RATE WAS 5.4% (N=21) AND LATE MORTALITY RATE WAS 21.5% (N=84). OF THE 105 DEATHS THAT OCCURRED, 39 WERE CARDIAC, 51 WERE NON-CARDIAC, AND 15 WERE DUE TO UNKNOWN CAUSES. OF THE 39 CARDIAC DEATHS, 6 WERE DEEMED VALVE-RELATED. NO FURTHER DETAILS WERE PROVIDED ON THESE DEATHS. BASED ON THE AVAILABLE INFORMATION MEDTRONIC PRODUCT WAS DIRECTLY ASSOCIATED WITH THE DEATH(S). AMONG ALL PATIENTS, ADVERSE EVENTS INCLUDED: THROMBO-EMBOLIC EVENTS; BLEEDING EVENTS; REOPERATIONS WERE PERFORMED FOR STRUCTURAL VALVE DYSFUNCTION (SVD), PARAVALVULAR LEAK (PVL), AND ENDOCARDITIS. BASED ON THE AVAILABLE INFORMATION MEDTRONIC PRODUCT WAS DIRECTLY ASSOCIATED WITH THE ADVERSE EVENT(S). NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 708940 | MOSAIC MITRAL BIOPROSTHETIC VALVE | HEART-VALVE, NON-ALLOGRAFT TISSUE | LWR | MEDTRONIC HEART VALVES DIVISION | 310 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 73 YR | Female | Life Threatening| R| H |